Home / Stocks / VNDA

VNDA insider trading

Vanda Pharmaceuticals Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
11
Bought · 24 mo
$514k
Buys · last 90 days
0 · $0
Most recent buy
2025-08-08

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-03-04Polymeropoulos Mihael Hristos
President and CEO
Sold156,235$8.17$1.3M
2025-08-08Polymeropoulos Mihael Hristos
President and CEO
Bought10,000$4.15$42k
2025-05-21Polymeropoulos Mihael Hristos
President and CEO
Bought10,000$4.40$44k
2025-05-19Polymeropoulos Mihael Hristos
President and CEO
Bought20,000$4.22$84k
2025-03-06Polymeropoulos Mihael Hristos
President and CEO
Bought10,000$5.01$50k
2025-03-05Polymeropoulos Mihael Hristos
President and CEO
Bought10,000$5.02$50k
2025-03-04Polymeropoulos Mihael Hristos
President and CEO
Bought10,000$4.71$47k
2025-02-28Polymeropoulos Mihael Hristos
President and CEO
Bought10,000$4.76$48k
2025-02-27Polymeropoulos Mihael Hristos
President and CEO
Bought10,000$4.76$48k
2025-02-26Polymeropoulos Mihael Hristos
President and CEO
Bought10,000$4.76$48k
2025-02-25Polymeropoulos Mihael Hristos
President and CEO
Bought10,000$4.46$45k
2025-02-24Moran Kevin Patrick
SVP, CFO & Treasurer
Bought2,000$4.39$9k

Most active insider buyers

InsiderRoleBuysTotal bought
Polymeropoulos Mihael HristosPresident and CEO10$505k
Moran Kevin PatrickSVP, CFO & Treasurer1$9k

See VNDA on the chart

Every insider buy and sell for VNDA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.